Moreover, cytidine deaminase (CDA) down-regulation and elevated dCTP pools have been associated to Bloom syndrome, a genetic rare disease produced by mutations in the BLM gene and characterized by defective DNA replication, high rates of sister chromatid exchange, a dramatic increase in the number of chromatin bridges and predisposition to cancer [44]. This evidence concerns the gene BLM and Bloom syndrome.